# FDA EIR - QuVa Pharma, Inc. - June 16, 2022

Source: https://www.globalkeysolutions.net/records/eir/quva-pharma-inc/7a53b3eb-2150-4f37-97c5-34f7cbfe4aa1

> FDA EIR for QuVa Pharma, Inc. on June 16, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: QuVa Pharma, Inc.
- Inspection Date: 2022-06-16
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2016-12-08](https://www.globalkeysolutions.net/records/483/quva-pharma-inc/e7c58cc6-8304-425b-9536-979bf8fd50f5)
- [483 - 2015-01-23](https://www.globalkeysolutions.net/records/483/quva-pharma-inc/8e479d93-55b2-4960-b0a3-8f086815d70d)
- [145 - 2018-05-22](https://www.globalkeysolutions.net/records/145/quva-pharma-inc/966e13dd-4e22-444e-ae56-d788740ac974)
- [483 - 2022-06-16](https://www.globalkeysolutions.net/records/483/quva-pharma-inc/ab15d9bd-3c3c-4119-b29d-a26e304a890b)
- [483 - 2014-06-20](https://www.globalkeysolutions.net/records/483/quva-pharma-inc/47aa03ba-b04e-4926-a794-a4b6ec4de663)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/travis-a-leeah/1406e1dd-f713-4a63-8d6d-59656e6018e3)
- [company_representative](https://www.globalkeysolutions.net/people/david-m-hartley/41598831-eaba-4fd4-b053-841312d44962)
- [Microbiologist](https://www.globalkeysolutions.net/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)
- [company_representative](https://www.globalkeysolutions.net/people/guy-l-thompson/60bd94e4-b34f-4852-8c93-c5c8c864dbcc)
- [company_representative](https://www.globalkeysolutions.net/people/kevin-white/78c06034-2807-4d5f-adcd-246b1d5a2cca)

Company: https://www.globalkeysolutions.net/companies/quva-pharma-inc/d524a08a-f9a6-49fd-8b83-e0508a9163f9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c